Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01688596 · ClinicalTrials.gov registry record · Phase 1

Injection of Local Anesthetic to Trocar Insertion Sites After Laparoscopy

A Phase 1 study, sponsored by Milton S. Hershey Medical Center.

Completed
Registry status
Phase 1
Development phase
135
Enrollment target

NCT01688596: Completed Phase 1 study, sponsored by Milton S. Hershey Medical Center.

NCT01688596 is a Phase 1 study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 135 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (125% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01688596, a Phase 1 study, has completed, sponsored by Milton S. Hershey Medical Center.

COMPLETED
Registry status
Phase 1
Development phase
135 participants
Enrollment target

Study Summary

The primary objective of this study is to assess if injection of local anesthetic to the laparoscopic trocar sites after a hysterectomy will make a difference in a patient's pain after surgery.

Primary Outcome

Postoperative pain is measured on day of surgery after trocar incisions are closed and injected with local anesthetic. Postoperative pain is evaluated with the Numerical Rating Scale (NRS) at 4 hrs after the surgery. The Numerical Rating Scale is a scale from 0 to 10 that measures pain severity, where 0 equates to "no pain" and 10 equates to "unable to move".

Interventions

  • DRUG Bupivacaine

Trial Details

FieldValue
Enrollment Target 135 participants
Start Date 2012-09
Est. Completion 2013-01
Phase Phase 1
Milton S. Hershey Medical Center

396 total trials

What the finished NCT01688596 record still lists

NCT01688596 is an interventional study that assigns participants to a tested intervention. The registered 135 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (125% higher).

The record links to 0 conditions, and to 1 intervention - of which Bupivacaine is the first listed.

NCT01688596 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01688596 about?

NCT01688596 is a clinical study titled "Injection of Local Anesthetic to Trocar Insertion Sites After Laparoscopy". The primary objective of this study is to assess if injection of local anesthetic to the laparoscopic trocar sites after a hysterectomy will make a difference in a patient's pain after surgery.

What is the current status of trial NCT01688596?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 135 participants. The study started on 2012-09. Estimated completion is 2013-01.

What interventions are being tested in trial NCT01688596?

The interventions under investigation include: Bupivacaine (DRUG).

Who is sponsoring clinical trial NCT01688596?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01688596's enrollment target sits among peer trials

135 425th of 2000 higher than 1,574 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00870129 · 135 participants · NA

    Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors

  • NCT03666000 · 135 participants · Phase 1

    Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

  • NCT04891510 · 135 participants · NA

    A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery

  • NCT05121051 · 135 participants · Phase 2

    Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01688596, the US trial registry maintained by the National Library of Medicine. NCT01688596 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.